Why is Ambey Laborator. falling/rising?

As of 03-Sep, Ambey Laboratories Ltd is currently priced at 42.75, reflecting a decline of 0.8, or 1.84%. The stock has underperformed its sector today by 1.7%. Despite showing higher performance than its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below the 200-day moving average. Over the past week, the stock has increased by 3.89%, but it has seen a significant decline of 32.94% year-to-date and 44.55% over the past year. There is a notable increase in investor participation, with delivery volume rising by 19.05% against the 5-day average, indicating a potential interest in the stock despite its overall negative performance. There are no positive or negative factors explicitly mentioned that could further clarify the stock's recent movement.
Broader market context shows that while Ambey Laboratories has struggled, the benchmark Sensex has performed relatively better, with a slight increase of 0.01% over the past week and a 4.53% gain year-to-date. This contrast highlights the stock's underperformance compared to the broader market, particularly given its substantial year-over-year decline. The stock's liquidity remains adequate for trading, but the overall negative returns suggest that investor sentiment may be cautious, contributing to the stock's downward price movement.